21 results on '"Ina, K."'
Search Results
2. Diagnostic capability of CMR for the diagnosis of acute myocarditis in young patients is determined by the presence of elevated cardiac enzymes
- Author
-
Schäufele Tim G, Rösch Sabine, Wenzelburger Ina K, Sechtem Udo P, and Yilmaz Ali
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2012
- Full Text
- View/download PDF
3. Locked Nucleic Acids—Properties and Applications
- Author
-
Mouritzen, Peter, primary, Wengel, Jesper, additional, Tolstrup, Niels, additional, Morgentaler Echwald, Søren, additional, Wahlin, Johan, additional, and Dahlsveen, Ina K., additional
- Published
- 2013
- Full Text
- View/download PDF
4. Locked Nucleic Acids—Properties and Applications
- Author
-
Ina K. Dahlsveen, Jesper Wengel, Søren Morgentaler Echwald, Johan Wahlin, Peter Mouritzen, and Niels Tolstrup
- Subjects
medicine.anatomical_structure ,Biochemistry ,Chemistry ,Nucleic acid ,medicine ,Appendix - Published
- 2013
5. FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study.
- Author
-
Iwamoto S, Takahashi T, Tamagawa H, Nakamura M, Munemoto Y, Kato T, Hata T, Denda T, Morita Y, Inukai M, Kunieda K, Nagata N, Kurachi K, Ina K, Ooshiro M, Shimoyama T, Baba H, Oba K, Sakamoto J, and Mishima H
- Subjects
- Adult, Aged, Aged, 80 and over, Bevacizumab administration & dosage, Camptothecin administration & dosage, Camptothecin analogs & derivatives, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Female, Fluorouracil administration & dosage, Follow-Up Studies, Humans, Irinotecan, Leucovorin administration & dosage, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local mortality, Neoplasm Recurrence, Local pathology, Neoplasm Staging, Organoplatinum Compounds administration & dosage, Oxaliplatin, Prognosis, Survival Rate, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Colorectal Neoplasms drug therapy, Neoplasm Recurrence, Local drug therapy, Salvage Therapy
- Abstract
Background: A targeted agent combined with chemotherapy is the standard treatment in patients with metastatic colorectal cancer (mCRC). The present phase III study was conducted to compare two doses of bevacizumab combined with irinotecan, 5-fluorouracil/leucovorin (FOLFIRI) in the second-line setting after first-line therapy with bevacizumab plus oxaliplatin-based therapy., Patients and Methods: Patients were randomly assigned to receive FOLFIRI plus bevacizumab 5 or 10 mg/kg in 2-week cycles until disease progression. The primary end point was progression-free survival (PFS), and secondary end points included overall survival (OS), time to treatment failure (TTF), and safety., Results: Three hundred and eighty-seven patients were randomized between September 2009 and January 2012 from 100 institutions in Japan. Baseline patient characteristics were well balanced between the two groups. Efficacy was evaluated in 369 patients (5 mg/kg, n = 181 and 10 mg/kg, n = 188). Safety was evaluated in 365 patients (5 mg/kg, n = 180 and 10 mg/kg, n = 185). The median PFS was 6.1 versus 6.4 months (hazard ratio, 0.95; 95% confidence interval [CI] 0.75-1.21; P = 0.676), and median TTF was 5.2 versus 5.2 months (hazard ratio, 1.01; 95% CI 0.81-1.25; P = 0.967), respectively, for the bevacizumab 5 and 10 mg/kg groups. Follow-up of OS is currently ongoing. Adverse events, including hypertension and hemorrhage, occurred at similar rates in both groups., Conclusion: Bevacizumab 10 mg/kg plus FOLFIRI as the second-line treatment did not prolong PFS compared with bevacizumab 5 mg/kg plus FOLFIRI in patients with mCRC. If bevacizumab is continued after first-line therapy in mCRC, a dose of 5 mg/kg is appropriate for use as second-line treatment., Clinical Trial Identifier: UMIN000002557., (© The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology.)
- Published
- 2015
- Full Text
- View/download PDF
6. Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals.
- Author
-
Hayashi T, Kubota K, Kawashima S, Sone H, Watanabe H, Ohrui T, Yokote K, Takemoto M, Araki A, Noda M, Noto H, Sakuma I, Yoshizumi M, Ina K, and Nomura H
- Subjects
- Aged, Aged, 80 and over, Case-Control Studies, Cholesterol, HDL antagonists & inhibitors, Cholesterol, HDL blood, Cohort Studies, Diabetes Mellitus, Type 2 epidemiology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Male, Prospective Studies, Risk Factors, Stroke epidemiology, Treatment Outcome, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Stroke blood, Stroke prevention & control
- Abstract
Background/objectives: HMG-CoA reductase inhibitors (statins) reduce ischemic heart disease (IHD) in middle-aged diabetic individuals, and LDL-cholesterol (LDL-C) is a risk factor. However, their preventive effects on cerebrovascular attack (CVA) have not been identified in elderly, especially in elderly ≥ 75 years (late elderly), who account for approximately 30% of diabetic individuals in Japan. Randomized controlled studies of statins for late elderly are difficult to carry out, because many co-morbidities in elderly disrupt randomized controlled conditions., Methods: We performed a prospective cohort study (Japan Cholesterol and Diabetes Mellitus Study) with 5.5 years of follow-up since 2004. A total of 4014 type 2 diabetic patients without previous IHD or CVA (n=1936 women; age = 67.4 ± 9.5 years; ≥ 75 years: n = 1016) were enrolled, while 405 patients were registered as sub-cohort patients. We recorded detailed information on medications and laboratory data after every change in medication in patients of sub-cohort and suffered from IHD or CVA. We subdivided statin-users into prevalent, new and non-users., Results: A total of 104 CVAs occurred during 5.5-years. Plasma HDL-C level was inversely correlated with CVA in patients ≥ 65 years. In case-control study, among patients who were not prescribed statins, CVA increased in age-dependent manner. CVA incidence was lower in prevalent and new statin-users than in non-users (hazard ratio [HR]:0.46, 0.523), especially in late elderly (HR: 0.51, 0.21). Statins reduced CVAs mainly due to a direct effect and partially due to the effects of HDL-C and glucose metabolism. No significant differences were observed between statins., Conclusion: Statins prevented CVA in middle-aged, elderly and late elderly diabetic patients via a direct effect. This study is the first to demonstrate the usefulness of observational studies for statistically analyzing agents' effects on late elderly., (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
7. Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability.
- Author
-
Morita M, Hayashi T, Ochiai M, Maeda M, Yamaguchi T, Ina K, and Kuzuya M
- Subjects
- Administration, Oral, Animals, Atherosclerosis prevention & control, Biological Availability, Cyclic GMP blood, Drug Synergism, Humans, Male, Rabbits, Rats, Rats, Sprague-Dawley, Signal Transduction drug effects, Arginine administration & dosage, Arginine blood, Citrulline administration & dosage, Dietary Supplements, Nitric Oxide blood
- Abstract
Background: Chronic supplementation with L-citrulline plus L-arginine has been shown to exhibit anti-atherosclerotic effects. However, the short-term action of this combination on the nitric oxide (NO)-cGMP pathway remains to be elucidated. The objective of the present study was to investigate the acute effects of a combination of oral L-citrulline and L-arginine on plasma L-arginine and NO levels, as well as on blood circulation., Methods: Rats or New Zealand white rabbits were treated orally with L-citrulline, or L-arginine, or a combination of each at half dosage. Following supplementation, plasma levels of L-arginine, NOx, cGMP and changes in blood circulation were determined sequentially., Results: L-Citrulline plus L-arginine supplementation caused a more rapid increase in plasma L-arginine levels and marked enhancement of NO bioavailability, including plasma cGMP concentrations, than with dosage with the single amino acids. Blood flow in the central ear artery in rabbits was also significantly increased by L-citrulline plus L-arginine administration as compared with the control., Conclusion: Our data show for the first time that a combination of oral L-citrulline and L-arginine effectively and rapidly augments NO-dependent responses at the acute stage. This approach may have clinical utility for the regulation of cardiovascular function in humans., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
8. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.
- Author
-
Ochiai M, Hayashi T, Morita M, Ina K, Maeda M, Watanabe F, and Morishita K
- Subjects
- Ankle Brachial Index, Arginine analogs & derivatives, Arginine blood, Blood Pressure physiology, Citrulline blood, Humans, Male, Middle Aged, Nitric Oxide blood, Nitric Oxide Synthase Type III metabolism, Placebos, Citrulline administration & dosage, Pulsatile Flow drug effects, Vascular Stiffness drug effects, Vascular Stiffness physiology
- Abstract
Background: Nitric oxide (NO) plays a key role in the maintenance of vascular tone, contributing to the functional regulation of arterial stiffness. Although oral L-citrulline could become the effective precursor of L-arginine (substrate for endothelial NO synthase) via the L-citrulline/ L-arginine pathway, little is known about the efficacy of L-citrulline application on arterial stiffness., Objective: We examined the short-term effects of L-citrulline supplementation on arterial stiffness in humans., Methods: In a double-blind, randomized, placebo-controlled parallel-group trial, 15 healthy male subjects (age: 58.3 ± 4.4 years) with brachial-ankle pulse wave velocity (baPWV; index of arterial stiffness >1400 cm/sec) were given 5.6g/day of L-citrulline (n=8) or placebo (n=7) for 7 days. baPWV and various clinical parameters were measured before (baseline) and after oral supplementation of L-citrulline or placebo., Results: Compared with the placebo group, baPWV was significantly reduced in the L-citrulline group (p<0.01). No significant differences in blood pressure (BP) were found between the two groups, and no correlation was observed between BP and baPWV. The serum nitrogen oxide (NOx, the sum of nitrite plus nitrate) and NO metabolic products were significantly increased only in the L-citrulline group (p<0.05). Plasma citrulline, arginine and the ratio of arginine/asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase (arginine/ADMA ratio) were significantly increased in the L-citrulline group compared with the placebo group (p<0.05, p<0.01, p<0.05, respectively). Moreover, there was a correlation between the increase of plasma arginine and the reduction of baPWV (r=-0.553, p<0.05)., Conclusion: These findings suggest that short-term L-citrulline supplementation may functionally improve arterial stiffness, independent of blood pressure, in humans., (Copyright © 2010. Published by Elsevier Ireland Ltd.)
- Published
- 2012
- Full Text
- View/download PDF
9. The effects of selective estrogen receptor modulator treatment following hormone replacement therapy on elderly postmenopausal women with osteoporosis.
- Author
-
Hayashi T, Ina K, Maeda M, and Nomura H
- Subjects
- Adiponectin blood, Aged, Blood Glucose analysis, Bone Density drug effects, Cholesterol, HDL blood, Cholesterol, HDL drug effects, Cholesterol, LDL blood, Cholesterol, LDL drug effects, Estriol therapeutic use, Estrogen Replacement Therapy, Female, Humans, Japan, Medroxyprogesterone therapeutic use, Nitric Oxide blood, Nitric Oxide metabolism, Prospective Studies, Tumor Necrosis Factor-alpha drug effects, Osteoporosis drug therapy, Postmenopause drug effects, Raloxifene Hydrochloride therapeutic use, Selective Estrogen Receptor Modulators therapeutic use
- Abstract
Objectives: A comparison between the atheroprotective and osteoprotective effects of the selective estrogen receptor modulator (SERM) raloxifene and those of hormone replacement therapy (HRT) has not been made in elderly women., Methods: A randomized prospective controlled trial was performed in a cohort of 32 elderly Japanese women with osteoporosis receiving HRT (estriol plus medroxyprogesterone) for more than 1 year. In 16 randomly selected subjects, HRT was changed to raloxifene therapy (60mg/day, 71.4±3.4 years, SERM group). The other 16 patients were continued on HRT (71.8±2.9 years, HRT group). As a control group, 14 subjects were enrolled, did not take any medications and were age-matched to experimental patients (72.5±3.3 years, control group). Plasma lipids, TNFα, adiponectin, NO metabolites (NOx:NO2(-) and NO3(-)), cyclicGMP and bone-mineral density (BMD) were evaluated at baseline and at 26 and 52 weeks after enrollment., Results: SERM (Raloxifene) increased high-density-lipoprotein cholesterol levels and tended to decrease low-density-lipoprotein cholesterol levels (P=0.058) compared with baseline. Adiponectin, NOx and cGMP levels were significantly increased after 6 months compared with baseline or the HRT group. TNFα was decreased by raloxifene. In control subjects, no significant changes were observed in any of these markers. Bone-mineral density was higher at baseline in the raloxifene and HRT groups than in the control group, and BMD increased 12 months after baseline in the HRT and control group., Conclusion: SERM improved BMD and endothelial function in elderly postmenopausal women with osteoporosis who had received HRT, and these effects were comparable to or slightly stronger than those of HRT. Changes in adiponectin and TNFα may underlie the improvements in endothelial function, such as NO signaling., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
10. The role of insulin growth factor on atherosclerosis and endothelial function: the effect on hyperlipidemia and aging.
- Author
-
Hirai H, Kanaya R, Maeda M, Qungfang D, Ina K, and Hayashi T
- Subjects
- Acetylcholine pharmacology, Animals, Aorta, Thoracic drug effects, Aorta, Thoracic pathology, Atherosclerosis pathology, Cholesterol, Dietary administration & dosage, Cyclic GMP blood, Drug Therapy, Combination, Endothelium, Vascular pathology, Hyperlipidemias pathology, Injections, Subcutaneous, Insulin-Like Growth Factor Binding Protein 3 metabolism, Lipids blood, Male, Nitric Oxide metabolism, Nitric Oxide Synthase metabolism, Rabbits, Signal Transduction drug effects, Vasodilator Agents pharmacology, Aging physiology, Atherosclerosis metabolism, Endothelium, Vascular metabolism, Hyperlipidemias metabolism, Insulin-Like Growth Factor I administration & dosage
- Abstract
Aims: Insulin/insulin-like growth factor (IGF-1) signaling is important for a variety of age-related processes. However, whether or not it affects atherosclerosis is unknown., Main Methods: Six groups of 6 male New Zealand white rabbits were treated for 12 weeks under the following conditions: Groups YC and YIGF: Young rabbits (10 weeks old) were fed regular chow w/wo IGF-1(Somazon 0.1 mg/kg/day, s.c.). Groups HC and HIGF: young rabbits were fed HCD (0.5% cholesterol plus regular chow) w/wo IGF-1. Groups OC and OIGF: old rabbits (120 weeks old) were fed regular chow w/wo IGF-1., Key Findings: Plasma lipid levels, endothelial responses and morphological findings did not differ between groups YIGF and YC. Animals in group HC had increased plasma lipid levels and atheromas. In group HIGF, IGF led to atheromas with increased plasma insulin growth factor binding protein 3 (IBP3), inducible nitric oxide synthase(iNOS) expression and nitrotyrosine staining, macrophage staining, SM1 staining and SM embryo staining compared to HC. Basal nitric oxide (NO) release evaluated by plasma NO metabolites (NOx) and cGMP levels were lowest in the HIGF group., Significance: Overall, IGF-1 promoted atherosclerosis by affecting endothelial function and aging. These findings indicate that Insulin/IGF1 may contribute to atherogenesis in the elderly., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
11. A hydroxymethylglutaryl coenzyme A reductase inhibitor improves endothelial function within 7 days in patients with chronic hemodialysis.
- Author
-
Kishimoto N, Hayashi T, Sakuma I, Kano-Hayashi H, Tsunekawa T, Osawa M, Ina K, and Iguchi A
- Subjects
- Aged, Brachial Artery drug effects, Brachial Artery enzymology, Endothelium, Vascular physiopathology, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Male, Middle Aged, Time Factors, Vasodilation drug effects, Vasodilation physiology, Endothelium, Vascular drug effects, Endothelium, Vascular enzymology, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Renal Dialysis trends
- Abstract
Background: Atherosclerosis-related diseases are leading causes of morbidity among patients undergoing hemodialysis. The effects of hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) on the endothelial function of hemodialyzed patients are not known., Methods and Results: For 16 weeks, we prescribed simvastatin (low dose: 5 mg or moderate dose: 10 mg) to 28 patients (low dose: n=14, 61.2 ± 8.6 years, moderate dose: n=14, 60.8 ± 10.2 years) and chose 9 patients (61.5 ± 5.2 years) without prescriptions as controls. We compared the effects of statin on lipids, flow-mediated endothelium-dependent and nitroglycerin-induced endothelium-independent dilatation (%FMD, %NTD), and markers of oxidant stress and atherosclerosis. Serum HDL-cholesterol and triglycerides did not change significantly in any of the three groups; however, LDL-cholesterol was decreased at 16 weeks in both simvastatin groups. The %FMD and plasma NOx increased at 1 and 16 weeks in both statin groups, but not in the control group (P<0.01). The %NTD did not change. Oxidized LDL, VCAM-1, and 8-isoprostane decreased significantly after 16 weeks in both statin groups; however, TNF-α and interleukin 6 did not change. In the control group, no significant changes in these parameters were observed. Multiple regression analyses showed that the (short) period of hemodialysis and (young) age are significant factors associated with %FMD improvement., Conclusions: A statin improved impaired endothelial function in the arteries of chronic dialysis patients, in part by enhancing NO bioavailability within one week. Improved endothelial function is in line with the anti-atherosclerotic effects observed in patients undergoing chronic hemodialysis., (Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
12. Role of endoscopic ultrasonography in predicting the response to cyclosporin A in ulcerative colitis refractory to steroids.
- Author
-
Watanabe O, Ando T, El-Omar EM, Shimada M, Ina K, Ishiguro K, Hasegawa M, Miyake N, Nakamura M, Miyahara R, Ohmiya N, Niwa Y, and Goto H
- Subjects
- Adult, Colon diagnostic imaging, Colon drug effects, Colon pathology, Colonoscopy methods, Endosonography, Female, Humans, Intestinal Mucosa diagnostic imaging, Intestinal Mucosa drug effects, Intestinal Mucosa pathology, Male, Middle Aged, Predictive Value of Tests, Prognosis, Prospective Studies, Young Adult, Colitis, Ulcerative diagnostic imaging, Colitis, Ulcerative drug therapy, Cyclosporine administration & dosage, Glucocorticoids administration & dosage, Immunosuppressive Agents administration & dosage
- Abstract
Background and Aims: Although cyclosporin A has been reported to be effective in the treatment of severe ulcerative colitis, factors predicting its therapeutic efficacy remain unclear. Technical progress in endoscopic ultrasonography has improved visualisation of the structure of the colon wall. Here, to assess the value of endoscopic ultrasonography in predicting the response to cyclosporin A treatment, we evaluated the therapeutic effect of cyclosporin A by determining the pre- and post-cyclosporin A thickness of the mucosal layer in the rectum using endoscopic ultrasonography with an ultrasonic catheter probe., Patients and Methods: Fifteen ulcerative colitis patients who did not respond to high-doses of corticosteroids were treated with cyclosporin A by continuous intravenous infusion at 4mg/kg/day for 20 days. Before and 20 days after cyclosporin A therapy, clinical disease activity was assessed using clinical activity index scores. Colonoscopy and endoscopic ultrasonography were undertaken before and 20 days after cyclosporin A therapy., Results: Following treatment with cyclosporin A, nine patients showed a decrease in clinical activity index score by six points or more and were defined as responders, while the other six were defined as non-responders. Endoscopic ultrasonography measurement using an ultrasonic catheter probe showed that thickness of the rectal mucosal layer before cyclosporin A was significantly greater in responders than in non-responders (p<0.05). Further, thickness after cyclosporin A was statistically decreased (p<0.01) in the responders but not in the non-responders., Conclusions: The ultrasonic catheter probe may represent a useful means of predicting and evaluating the efficacy of cyclosporin A treatment in severely ill ulcerative colitis patients.
- Published
- 2009
- Full Text
- View/download PDF
13. Clinical factors such as B-type natriuretic peptide link to factor VII, endothelial NO synthase and estrogen receptor alpha polymorphism in elderly women.
- Author
-
Funami J, Hayashi T, Nomura H, Ding QF, Ishitsuka-Watanabe A, Matsui-Hirai H, Ina K, Zhang J, Yu ZY, and Iguchi A
- Subjects
- Aged, Aged, 80 and over, Atherosclerosis blood, DNA genetics, Estrogen Receptor alpha genetics, Factor VII genetics, Female, Genotype, Humans, Japan, Middle Aged, Nitric Oxide Synthase Type III genetics, Thrombosis blood, Aging genetics, Atherosclerosis genetics, Natriuretic Peptide, Brain blood, Polymorphism, Single Nucleotide, Thrombosis genetics
- Abstract
Aims: This study evaluated the presence of genetic mutations in relation to thrombosis or atherosclerosis in elderly women., Main Methods: This is an observational study of 93 Japanese women with a mean age of 80.9 years recruited from outpatient clinics of Nagoya University and its related hospitals. Ten single nucleotide polymorphisms (SNPs) were studied. Each gene studied acts in or is related to either blood coagulation (factor V Leiden, prothrombin G20210A, factor XIII Val34Leu, factor VII Arg353Gln, MTHFR C677T, beta-fibrinogen G-455A, PAI-1 4G/5G), metabolic syndrome-related pathways (PPARalpha Leu162Val), or endothelium/estrogen system (eNOS Glu298Asp, ERalpha IVS1-401). SNPs were analyzed for their relation to clinical values including lipids, B-type natriuretic peptide (BNP), fasting plasma glucose, tumor necrosis factor-alpha, interleukin-6, cyclic GMP, and nitric oxide metabolites., Key Findings: Comparisons between the distributions of different genotypes and clinical values showed three relationships. First, factor VII Arg353Gln and HDL-cholesterol (HDL-C) were linked to Arg/Arg carriers at higher levels (P=.049). The HDL-C to LDL-cholesterol ratio supported this link (P=.027). Second, eNOS Glu298Asp and triglycerides were linked to Glu/Glu carriers at higher levels (P=.031). Third, ERalpha IVS1-401 and BNP were related to CC genotype at lower levels (P=.031). Additionally, the last two relations showed that genotype does not influence the demarcation line of biomarkers, but the plasma/serum levels of biomarkers instead., Significance: Correlations of factor VII Arg353Gln with HDL-C and eNOS Glu298Asp with triglycerides are new findings. Polymorphisms in the endothelium/estrogen system and the heart failure marker BNP are also correlated, with ERalpha IVS1-401 being the first identified marker. SNPs may be helpful for understanding the pathophysiology of atherosclerotic diseases in elderly women.
- Published
- 2009
- Full Text
- View/download PDF
14. Intracellular formation of collagen microfibrils in granulation tissue.
- Author
-
Ina K, Kitamura H, Tatsukawa S, Miyazaki T, Abe H, and Fujikura Y
- Subjects
- Actins metabolism, Actins ultrastructure, Animals, Cytoplasmic Vesicles metabolism, Cytoplasmic Vesicles ultrastructure, Endoplasmic Reticulum, Rough metabolism, Endoplasmic Reticulum, Rough ultrastructure, Fibroblasts metabolism, Fibroblasts ultrastructure, Golgi Apparatus metabolism, Golgi Apparatus ultrastructure, Granulation Tissue metabolism, Male, Microscopy, Electron, Transmission, Microscopy, Immunoelectron, Mitochondria ultrastructure, Procollagen metabolism, Procollagen ultrastructure, Rats, Rats, Sprague-Dawley, Secretory Vesicles metabolism, Secretory Vesicles ultrastructure, rab3A GTP-Binding Protein metabolism, Fibrillar Collagens metabolism, Fibrillar Collagens ultrastructure, Granulation Tissue ultrastructure
- Abstract
It is important to determine the biosynthesis process of collagen fibers to elucidate the mechanism by which granulation tissue is induced after injury. The purpose of this study is to investigate whether collagen microfibrils can be formed not only outside but also inside a cell. Fibroblast-like cells in granulation tissue resulting from incision and ligation were examined. The cells possessed vesicles containing collagen microfibrils. The vesicles were present in connection with Golgi apparatus or the rough endoplasmic reticulum. Furthermore, the vesicles were exhibited to be secretory granules with the secretory granule marker Rab3A. The fibroblast-like cells were also indicated to be myofibroblasts, using conventional transmission electron microscopy and immunoelectron microscopy for the myofibroblast marker alpha smooth muscle actin. In conclusion, it was demonstrated that collagen microfibrils could be formed in the cell in the case of collagen fiber overproduction.
- Published
- 2005
- Full Text
- View/download PDF
15. Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
- Author
-
Nobata K, Ina K, Ohta M, Kawamura-Sato K, Tsuzuki T, Ando T, and Kusugami K
- Subjects
- Binding, Competitive drug effects, Disease Susceptibility, Dose-Response Relationship, Drug, Drug Resistance, Microbial genetics, Epithelial Cells drug effects, Gastric Mucosa metabolism, Helicobacter Infections drug therapy, Helicobacter Infections enzymology, Helicobacter Infections microbiology, Helicobacter pylori enzymology, Helicobacter pylori isolation & purification, Humans, Peptic Ulcer drug therapy, Peptic Ulcer enzymology, Peptic Ulcer microbiology, Treatment Outcome, Urease drug effects, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Clarithromycin pharmacology, Clarithromycin therapeutic use, Epithelial Cells metabolism, Gastrointestinal Motility drug effects, Helicobacter pylori drug effects, Stomach cytology, Urease metabolism
- Abstract
Background: Our previous study showed that histological scores of gastric mucosal inflammation and Helicobacter pylori density decreased even in patients who failed to eradicate Helicobacter pylori after antimicrobial therapy including clarithromycin. This may reflect indirect suppressive effects of lower concentrations of clarithromycin on Helicobacter pylori, as suggested in other Gram-negative rod infections., Aims: To investigate whether clarithromycin suppresses virulence factors of Helicobacter pylori at sub-minimal inhibitory concentration., Methods: Six clarithromycin-susceptible Helicobacter pylori isolates and 7 clarithromycin-resistant isolates were obtained from patients with peptic ulcer disease. These isolates were analysed for urease activity, motility, and ability to bind to gastric epithelial cells after they were incubated with or without clarithromycin at sub-minimal inhibitory concentrations., Results: Incubation of Helicobacter pylori isolates with clarithromycin at sub-minimal inhibitory concentrations reduced urease activity motility, and binding to gastric epithelial cells in a dose-dependent manner. These findings were observed both in clarithromycin-susceptible and resistant strains., Conclusions: Suppressive effects of clerithromycin on virulence factors of Helicobacter pylori at sub-minimal inhibitory concentrations may be associated with observed attenuation of gastric inflammation and Helicobacter pylori density in patients who failed in bacterial eradication after triple therapy including clarithromycin.
- Published
- 2002
- Full Text
- View/download PDF
16. Troxipide, a novel antiulcer compound, has inhibitory effects on human neutrophil migration and activation induced by various stimulants.
- Author
-
Kusugami K, Ina K, Hosokawa T, Kobayashi F, Kusajima H, Momo K, and Nishio Y
- Subjects
- Adult, Cell Culture Techniques, Chromatography, High Pressure Liquid, Helicobacter Infections immunology, Humans, Inflammation, Intestinal Mucosa, Neutrophils drug effects, Stomach Ulcer immunology, Stomach Ulcer physiopathology, Superoxides, Anti-Ulcer Agents pharmacology, Cell Movement drug effects, Chemotaxis drug effects, Helicobacter Infections physiopathology, Neutrophils physiology, Piperidines pharmacology
- Abstract
Background: Neutrophils are considered to be involved in the pathogenesis of Helicobacter pylori-associated gastroduodenal diseases on account of their potent biological functions as effector cells. Troxipide, a new antiulcer compound used for patients with gastric ulcer or gastritis, has been shown to inhibit migration and activation of guinea pig neutrophils, but little is known about the pharmacological effects on human neutrophils., Aims: To study the effects of troxipide on chemotactic migration and superoxide generation by human neutrophils., Methods: The chemotactic response of neutrophils was determined in a multi-well chamber with a polycarbonate filter and the generation of O2- by neutrophils was measured using a chemiluminescence method. Concentrations of troxipide in gastric mucosa were measured by high-performance liquid chromatography., Results: Incubation of neutrophils with 10(-6) to 10(4) M troxipide caused inhibition of recombinant interleukin-8-induced migration. These concentrations of troxipide also inhibited superoxide generation by neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine or platelet activating factor. These phenomena were not simply due to the direct cytotoxic effects since the above concentrations of troxipide did not induce neutrophil apoptosis. The concentrations of troxipide detected in the gastric mucosa after oral administration were in the range able to inhibit chemotactic migration and superoxide generation by neutrophils in vitro., Conclusion: These results suggest that troxipide may exert its therapeutic effect in patients with gastric ulcer or gastritis by inhibiting inflammatory responses and mucosal injury mediated by neutrophils in gastric mucosa.
- Published
- 2000
- Full Text
- View/download PDF
17. Linalyl and bornyl disaccharide glycosides from Gardenia jasminoides flowers.
- Author
-
Watanabe N, Nakajima R, Watanabe S, Moon JH, Inagaki J, Sakata K, Yagi A, and Ina K
- Subjects
- Camphanes isolation & purification, Carbohydrate Sequence, Chromatography, Gas, Disaccharides isolation & purification, Gas Chromatography-Mass Spectrometry, Glycosides isolation & purification, Magnetic Resonance Spectroscopy, Molecular Sequence Data, Terpenes isolation & purification, Camphanes chemistry, Disaccharides chemistry, Glycosides chemistry, Monoterpenes, Plants chemistry, Terpenes chemistry
- Abstract
(R)-Linalyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside and bornyl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside were isolated as aroma precursors of linalool and borneol from flower buds of Gardenia jasminoides, guided by enzymatic hydrolysis followed by GC and GC-MS analyses.
- Published
- 1994
- Full Text
- View/download PDF
18. Geranyl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside isolated as an aroma precursor from tea leaves for oolong tea.
- Author
-
Guo W, Sakata K, Watanabe N, Nakajima R, Yagi A, Ina K, and Luo S
- Subjects
- Carbohydrate Sequence, Disaccharides chemistry, Magnetic Resonance Spectroscopy, Molecular Sequence Data, Smell, Terpenes chemistry, Disaccharides isolation & purification, Tea chemistry, Terpenes isolation & purification
- Abstract
A new geranyl glycoside, geranyl 5-O-beta-D-xylopyranosyl-beta-D-glucopyranoside was isolated as an aroma precursor from tea leaves (Camellia sinensis var. sinensis cv Shuixian) for oolong tea. The isolation was guided by a two-phase acid hydrolysis and/or an enzymatic hydrolysis followed by GC and GC-MS analyses.
- Published
- 1993
- Full Text
- View/download PDF
19. Loss of sulfated carbohydrate from the glomerular podocyte as a cause of albuminuria in experimental diabetic rats: ultrastructural histochemical study.
- Author
-
Ina K, Kitamura H, Nakamura M, Ono J, and Takaki R
- Subjects
- Animals, Basement Membrane pathology, Diabetes Mellitus, Experimental physiopathology, Diabetic Nephropathies pathology, Diabetic Nephropathies physiopathology, Heparan Sulfate Proteoglycans, Kidney Cortex pathology, Kidney Glomerulus pathology, Male, Microscopy, Electron, Rats, Rats, Inbred Strains, Albuminuria, Basement Membrane ultrastructure, Diabetes Mellitus, Experimental pathology, Heparitin Sulfate analysis, Kidney Cortex ultrastructure, Kidney Glomerulus ultrastructure, Proteoglycans analysis
- Abstract
Decrease of anionic sites and heparan sulfate proteoglycan has been demonstrated in diabetic glomerular basement membrane (GBM) and causally related to albuminuria. The HID-TCH-SP-PD technique is a sensitive histochemical method for negatively charged sulfated carbohydrates. In this study, we examined the localization of HID-TCH-SP-PD reaction in the glomeruli of diabetic and control rats. In both rats, the reaction was found in association with the surface of podocytes and with GBM. In diabetic rats, the former-associated reaction was markedly reduced. By contrast, the latter-associated reaction did not show any differences between both animal groups. Urinary albumin excretion (UAE) increased significantly in alloxanized rats. It is suggested that a decrease of podocyte-associated sulfated carbohydrates, the primary observed change, gives rise to albuminuria in alloxan diabetic rats.
- Published
- 1991
- Full Text
- View/download PDF
20. Effects of various isolation methods for human peripheral lymphocytes on T cell subsets determined in a fluorescence activated cell sorter (FACS), and demonstration of a sex difference of suppressor/cytotoxic T cells.
- Author
-
Iwatani Y, Amino N, Mori H, Asari S, Ina K, Ennyu K, and Miyai K
- Subjects
- Adult, B-Lymphocytes immunology, Cell Adhesion, Erythrocytes physiology, Female, Humans, Male, Monocytes, Phenotype, Rosette Formation, Sex Characteristics, Cell Separation methods, Flow Cytometry, T-Lymphocytes classification, T-Lymphocytes, Cytotoxic immunology, T-Lymphocytes, Regulatory immunology
- Abstract
The effects of various methods for removal of monocytes and residual erythrocytes from human peripheral blood mononuclear cells (PBMC) on T cell subsets were examined. T cell subsets were determined in a fluorescence activated cell sorter (FACS) using fluorescein-conjugated monoclonal antibodies (anti-Leu-1, anti-Leu-2a and anti-Leu-3a antibodies). Removal of monocytes by methods based on adherence or phagocytosis decreased yields of lymphocytes and caused changes in the percentage and/or the fluorescence intensity of T cell subsets. Exclusion of monocytes from the FACS analysis by setting of the scatter gates was incomplete (about 80%). Removal of residual erythrocytes after Ficoll separation by ammonium chloride treatment also changed the percentage of T cell subsets. A method using PBMC without removal of monocytes and erythrocytes was chosen as best and simplest for routine use in FACS analysis of lymphocytes. Erythrocytes could be excluded from the FACS analysis by setting the scatter gates and the percentage of T cell subsets was corrected after measurement of monocytes, identified by peroxidase staining. The reproducibility of measurements of T cell subsets made at different times was examined using PBMC obtained from the same healthy man during 12 weeks. For standardization of the assay, the peak positions of scatter and fluorescence intensity of each PBMC labeled with anti-Leu-3a were adjusted to standard values in each FACS analysis. Under these conditions, variations of other parameters of this standard PBMC were very small in 12 different assays. Using this standard PBMC, satisfactory, reproducible results were also observed on PBMC obtained from another normal subject. Therefore, this standard PBMC labeled with anti-Leu-3a was used as a standard in FACS analysis. Under these accurately standardized conditions, it was demonstrated that the peak position of fluorescence intensity of Leu-2a (suppressor/cytotoxic T) cells was significantly lower (P less than 0.01) in women than in men.
- Published
- 1982
- Full Text
- View/download PDF
21. Isolation and structure elucidation of theaspirone, a component of tea essential oil.
- Author
-
Ina K and Sakato Y
- Subjects
- Chemical Phenomena, Chemistry, Lactones, Odorants, Spiro Compounds, Oils, Volatile analysis, Tea analysis
- Published
- 1968
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.